A Shareholders’ Committee (SC) has been created by RTIX shareholders. The Committee believes that the Regeneration Biologics Board of Directors must take immediate action to prevent a further erosion of shareholder value. In the past twelve months the Company's value has declined by half and has declined nearly 80% since August of 2007. How has this happened?
This has happened This has happened on current management’s watch. The Shareholder’s Committee seeks to alert shareholders of the Committee’s formation. The Committee’s agenda is to table a set of proposals to the Company’s Board of Directors. The agenda will also include proposals to consider and review:
contracts
agreements
real estate obligations
sale of German operations
sale of the Company
Manfred Krueger, President and Chief Executive Officer of Tutogen Medical
George Lombardi, former Chief Financial Officer, Tutogen Medical
Eugene Roelke, former Board Member of Tutogen Medical
Michael Brod, former consultant to Tutogen Medical
contact:
Gene Roelke Shareholder Committee
g.e.roelke@gmail.com
